Due to its function and distinct expression pattern, the human equilibrative nucleoside transporter 1 (hENT1) has been widely investigated as a potentially predictive or prognostic biomarker for many tumor types, including cholangiocarcinoma (Randazzo et al., 2020). Here, SLC29A1 is linked to cholangiocarcinoma.